COVID-19 and Diabetes: Understanding New Onset Hyperglycemia
Author Information
Author(s): Sultana Kakoly Nadira, Hasan S. M. Kamrul, Hoque Mohammad Mahfuzul, Ratul Rifat Hossain, Khan Md. Abdullah Saeed, Mitra Dipak Kumar, Billah Baki
Primary Institution: North South University
Hypothesis
This study aimed to compare the sociodemographic factors, clinical characteristics, and outcomes between COVID-19 patients with new onset hyperglycemia and those with pre-existing diabetes.
Conclusion
The study highlights the clinical trajectory of new-onset hyperglycemia in COVID-19 patients and emphasizes the need for diligent monitoring and management post-discharge.
Supporting Evidence
- 30.18% of patients had new onset hyperglycemia.
- 69.8% had pre-existing diabetes.
- 29 patients died in the hospital.
- Four patients left against medical advice.
- 135 out of 136 survivors attended follow-up two weeks after discharge.
Takeaway
This study looked at how COVID-19 affects people with diabetes and those who develop high blood sugar for the first time, showing that many need careful follow-up after leaving the hospital.
Methodology
A prospective observational study was conducted among adult COVID-19 patients with new onset hyperglycemia or pre-existing diabetes admitted to the COVID-19 unit of Dhaka Medical College Hospital.
Potential Biases
Potential bias due to the convenience sampling method and the exclusion of critically ill patients.
Limitations
The study has limitations including a small sample size, data collected from a single center, and a short follow-up time.
Participant Demographics
Average age of patients was 56.38 years, with 60.36% male and 51.83% from rural areas.
Statistical Information
P-Value
p = 0.003 for smoking prevalence
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website